Merit

For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Healing & Recovery

BPC-157 + KPV

Also known as: BPC-157/KPV blend, BPC-157 KPV

Research use only · not FDA-approved

Pre-mixed blend of two component peptides marketed for tissue repair and inflammation. BPC-157 is a synthetic pentadecapeptide (sequence GEPPPGKPADDAGLV) derived from a gastric protective protein, studied in animals for tendon/ligament and GI healing, partly via the VEGFR2/angiogenesis pathway. KPV is the C-terminal tripeptide (Lys-Pro-Val) of alpha-MSH that acts as an anti-inflammatory agent, primarily by inhibiting NF-kB signaling without melanocortin-receptor activation. Neither component is FDA-approved for human use, and there is no controlled human efficacy or safety data for this specific combination — the rationale is inferred from the individual grey-market research peptides.

Where to buy · live market data

Who's worth your money for BPC-157 + KPV

Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.

Average price

—/mg

Sellers

1

45-day trend

building…

0 of 1 sellers have a current price

Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.

Watch BPC-157 + KPV

Get one email when the market actually moves — no newsletter, no noise.

Compound reference

About BPC-157 + KPV

CAS

—

Molecular formula

—

Typical dose range

Vendor-dependent; component norms: BPC-157 250-500 mcg/day subcutaneous; KPV 200-500 mcg/day subcutaneous or oral. No validated combination dosing exists.

Half-life

BPC-157: disputed (under 30 minutes per most pharmacokinetic data); KPV: short (minutes to a few hours, not well characterized in humans)

Common research uses

soft-tissue and tendon injury recovery (research only)gut inflammation and IBD-model support (research only)general anti-inflammatory and recovery stacking (research only)

Safety notes

Not FDA-approved for human therapeutic use; sold as a research-only / grey-market blend. No combination-specific human safety data. Component risks are extrapolated from limited animal and early human research only. Not evaluated by WADA as a blend.

Reconstitution

Reconstitute lyophilized powder with bacteriostatic water; refrigerate after reconstitution.

Independent evidence

COAs for BPC-157 + KPV

2 third-party tests across 2 vendors. Each card links to the full report.

All 2 COAs for BPC-157 + KPV →
—
Measured purity over time
Aggregated · 3rd-party listing
—
Mar 2026

Purity not on file

Vanguard Laboratory Strong

For

BPC-157/KPV

by Mile High Compounds· batch KPC-001-MH-01

Aggregated · 3rd-party listing
—

Purity not on file

Vanguard Laboratory Strong

For

BPC-157/KPV

by Glacier Aminos· batch KBC0012026-01

Research depth

1 citations indexed for BPC-157 + KPV

All research on BPC-157 + KPV →

Study · 2026

Scrolling for science: Assessing the quality and accuracy of Crohn's disease-related content on Instagram reels

Background There is a concerning trend of misinformation of healthcare related content on social media. Recent studies have examined themes and narratives about Crohn's disease but have not quantitatively assessed the accuracy and quality of content on Instagram Reels.

Research use only — not for human consumption and not approved by the FDA. Nothing here is medical advice.